2024
DOI: 10.1021/acs.jafc.3c07935
|View full text |Cite
|
Sign up to set email alerts
|

The Anti-inflammatory Potential of a Strain of Probiotic Bifidobacterium pseudocatenulatum G7: In Vitro and In Vivo Evidence

Yukun Sun,
Jiazhi Zhou,
Hengjun Du
et al.

Abstract: The genus Bifidobacterium has been widely used in functional foods for health promotion due to its beneficial effects on human health, especially in the gastrointestinal tract (GIT). In this study, we characterize the anti-inflammatory potential of the probiotic strain Bifidobacterium pseudocatenulatum G7, isolated from a healthy male adult. G7 secretion inhibited inflammatory response in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. Moreover, oral administration of bacteria G7 alleviated the seve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 43 publications
0
1
0
Order By: Relevance
“…Lactobacillus rhamnosus CY12 has been demonstrated to ameliorate colitis through modulation of the gut microbiota, restoration of intestinal barrier function, and suppression of the TLR4-MyD88-NF-κB pathway Bifidobacterium pseudocatenulatum G7 has been found to alleviate colitis by addressing gut microbiota dysbiosis and regulating bile acid and short-chain fatty acid (SCFA) levels . Moreover, Lactiplantibacillus plantarum AS21 has shown promise in improving DSS-induced colitis by modulating the gut microbiota, enhancing intestinal function, and inhibiting the p38-MAPK/NF-κB pathway in colonic tissues, thereby mitigating inflammation and oxidative stress .…”
Section: Discussionmentioning
confidence: 99%
“…Lactobacillus rhamnosus CY12 has been demonstrated to ameliorate colitis through modulation of the gut microbiota, restoration of intestinal barrier function, and suppression of the TLR4-MyD88-NF-κB pathway Bifidobacterium pseudocatenulatum G7 has been found to alleviate colitis by addressing gut microbiota dysbiosis and regulating bile acid and short-chain fatty acid (SCFA) levels . Moreover, Lactiplantibacillus plantarum AS21 has shown promise in improving DSS-induced colitis by modulating the gut microbiota, enhancing intestinal function, and inhibiting the p38-MAPK/NF-κB pathway in colonic tissues, thereby mitigating inflammation and oxidative stress .…”
Section: Discussionmentioning
confidence: 99%